Health | Biotechnology | Pharmaceutical ... Tempus Announces Four Abstracts Accepted for Presentation at the 2024 San Antonio Breast Cancer Symposium.
News
- Houston Medicine Magazine Headlines Powered By Business Wire
- Arvinas Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial ...
... San Antonio Breast Cancer Symposium (“SABCS”) in San Antonio, Texas on ... $ARVN. Biotechnology: Pharmaceutical Preparations. Health Care. Medical/ ...
- Tempus Announces Four Abstracts Accepted for Presentation at the 2024 San Antonio ...
... San Antonio Breast Cancer Symposium, which convenes from December 10-13 ... Sarepta, Biotech's Regulatory Go-Getter, Signs Standout Rare Disease Deal.
- Lexaria Bioscience engages CRO for human pilot study of DehydraTEHC-liraglutide
Lexaria Bioscience (LEXX) announced the engagement of a ... These data will be presented at the 2024 San Antonio Breast Cancer Symposium.
- Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub ... - MarketScreener
These data will be presented in a poster at the 2024 San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas. ... Biotechnology & Medical ...